McGuire Investment Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,728
| Closed | -$145K | – | 114 |
|
|
2024
Q4 | $145K | Sell |
11,728
-21,106
| -64% | -$242K | 0.02% | 109 |
|
|
2024
Q3 | $374K | Sell |
32,834
-3,991
| -11% | -$40.1K | 0.05% | 95 |
|
|
2024
Q2 | $263K | Sell |
36,825
-103
| -0.3% | -$788 | 0.04% | 106 |
|
|
2024
Q1 | $247K | Hold |
36,928
| – | – | 0.04% | 111 |
|
|
2023
Q4 | $240K | Sell |
36,928
-9,950
| -21% | -$64.1K | 0.04% | 110 |
|
|
2023
Q3 | $443K | Sell |
46,878
-10,057
| -18% | -$121K | 0.09% | 77 |
|
|
2023
Q2 | $795K | Hold |
56,935
| – | – | 0.15% | 70 |
|
|
2023
Q1 | $1.07M | Sell |
56,935
-6,537
| -10% | -$107K | 0.21% | 64 |
|
|
2022
Q4 | $874K | Sell |
63,472
-515
| -0.8% | -$7.89K | 0.19% | 66 |
|
|
2022
Q3 | $1.22M | Sell |
63,987
-3,631
| -5% | -$66.2K | 0.28% | 60 |
|
|
2022
Q2 | $1.03M | Hold |
67,618
| – | – | 0.22% | 65 |
|
|
2022
Q1 | $1.38M | Buy |
67,618
+71
| +0.1% | +$1.45K | 0.25% | 57 |
|
|
2021
Q4 | $1.97M | Sell |
67,547
-394
| -0.6% | -$11.3K | 0.32% | 50 |
|
|
2021
Q3 | $1.47M | Sell |
67,941
-16,227
| -19% | -$392K | 0.28% | 48 |
|
|
2021
Q2 | $2.16M | Buy |
84,168
+3,086
| +4% | +$65.9K | 0.41% | 48 |
|
|
2021
Q1 | $1.48M | Buy |
81,082
+21,822
| +37% | +$363K | 0.31% | 47 |
|
|
2020
Q4 | $684K | Buy |
59,260
+12,129
| +26% | +$111K | 0.17% | 59 |
|
|
2020
Q3 | $359K | Buy |
47,131
+11,932
| +34% | +$90.4K | 0.11% | 77 |
|
|
2020
Q2 | $231K | Buy |
35,199
+21,899
| +165% | +$122K | 0.08% | 83 |
|
|
2020
Q1 | $68K | Buy |
+13,300
| New | +$80.5K | 0.03% | 81 |
|
Other funds holding CDMO
McGuire Investment Group's CDMO Position: Q1 2025 in Review
McGuire Investment Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 11,728 shares — an estimated $145K sold.
McGuire Investment Group first reported a position in CDMO in Q1 2020 and held it in 20 quarters. The position peaked at $2.16M in Q2 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- McGuire Investment Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- McGuire Investment Group sold 11,728 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $145K.
- McGuire Investment Group first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2020 and held it in 20 quarters.
- McGuire Investment Group's Avid Bioservices, Inc. Common Stock position peaked at $2.16M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on McGuire Investment Group's 13F filing for Q1 2025, filed 25 Apr 2025.